Deltanoid Pharmaceuticals is a drug development company
involved in breakthrough treatments for osteoporosis, renal
osteodystrophy, psoriasis and other disease targets. The company
specializes in designing advanced vitamin D analogs, and several
of its vitamin D-based therapies are already being tested in
human clinical trials. Deltanoid will develop therapies through
early stage human trials and will then seek partners to conduct
later stage human trials and commercialize the products.